Publication Alert: T1D Screening Consensus Guidance is Here
New Publication Alert! Breakthrough T1D spearheaded a paper titled “International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes” that was published in Diabetologia. This is an important step toward integrating general population screening for type 1 diabetes (T1D) into clinical practice globally. Read on to learn more about […]
Training the Next Generation: Meet our Research Interns
To accomplish our mission of a world without type 1 diabetes (T1D), one thing is clear: the more minds we have thinking about T1D, the better. That’s why Breakthrough T1D brings in interns each year, including in our Research department. Training the next generation isn’t just about career development—it’s about fresh eyes, new ideas, diverse […]
Changing the Diagnosis Story: Building Solutions for T1D Risk Screening
This article was written by Francine Maloney, MPH (Director, Implementation and Director, U.S. Coalition for Early T1D Action) and Umila Singh, MFA (Design Specialist, Innovation) from Ariadne Labs at Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health. The U.S. Coalition for Early T1D Action has utilized our Participant Advisory Council (PAC) […]
Ride Pat Ride: Pedaling Across the Plains for T1D
On July 15, Pat McAleer flew from Richmond, VA, to Seattle, WA, dipped his bike in the Pacific Ocean at La Push, WA, and embarked on Ride Pat Ride—a solo, 5,000+ mile, three-month journey to the Atlantic Ocean at Virginia Beach, VA, all to raise money for type 1 diabetes (T1D) cures. We first checked […]
Abbott’s Dual Glucose-Ketone Sensing Technology Approved in the U.S.
What’s Happening? The U.S. Food and Drug Administration (FDA) approved Abbott’s Libre Duo 10 Day, the world’s first two-in-one sensor that monitors both glucose and ketones. People with diabetes ages two and up will soon be able to access this technology in the U.S. This follows from its recent approval in Europe earlier this year. […]
A New Tool to Accurately Diagnose Type 1 in Adults
Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA partnered up to tackle it—and the results were just published.
Navigating Back to School with T1D: Tips and Tricks from a North Carolina Family
Vale Long was diagnosed with type 1 diabetes (T1D) in December 2025, when she was 9 years old. The Wilmington, North Carolina fourth grader says managing her T1D is all about planning ahead. “Every time before I leave the house, I always make sure my pump’s good, I have my glucagon, I have some sugar […]
An Interview with Breakthrough T1D-Funded Researchers
A cornerstone of Breakthrough T1D is awarding funding to scientists, researchers, and clinicians who are embarking on promising type 1 diabetes (T1D) research projects. The research we fund spans across the entire spectrum of T1D, including underlying biological and genetic causes, new approaches to cures, advanced technologies, clinical trials, and more. Here, we feature Remi […]
Ride Pat Ride: Cycling from the Pacific to the Atlantic for T1D
Embarking on a cross-country cycling odyssey requires a lot of planning. For Pat McAleer, the journey began in 2009, when his daughter Mary Kate was diagnosed with type 1 diabetes (T1D) at 10 years old, as she navigated the daily challenges of this condition with incredible strength. “Since then, my wife Molly and I have […]
Global Summit to End Diabetes Stigma
The inaugural Global Summit to End Diabetes Stigma aimed to confront and reduce the stigma that impacts the lives of people with diabetes.
